Compare ABR & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABR | OMCL |
|---|---|---|
| Founded | 2003 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Computer Manufacturing |
| Sector | Real Estate | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.6B |
| IPO Year | 2003 | 2000 |
| Metric | ABR | OMCL |
|---|---|---|
| Price | $5.03 | $33.41 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 6 |
| Target Price | $9.90 | ★ $55.83 |
| AVG Volume (30 Days) | ★ 4.1M | 785.7K |
| Earning Date | 05-08-2026 | 04-28-2026 |
| Dividend Yield | ★ 15.42% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.77 |
| Revenue | N/A | ★ $787,309,000.00 |
| Revenue This Year | N/A | $6.77 |
| Revenue Next Year | N/A | $5.22 |
| P/E Ratio | ★ N/A | $43.44 |
| Revenue Growth | N/A | ★ 9.93 |
| 52 Week Low | $4.73 | $29.06 |
| 52 Week High | $12.58 | $51.84 |
| Indicator | ABR | OMCL |
|---|---|---|
| Relative Strength Index (RSI) | 45.42 | 31.57 |
| Support Level | $4.94 | $33.25 |
| Resistance Level | $5.45 | $35.62 |
| Average True Range (ATR) | 0.15 | 1.09 |
| MACD | -0.01 | -0.18 |
| Stochastic Oscillator | 25.64 | 9.20 |
Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily, SFR, and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.